Dmitry Popov
Gründer bei Maxwell Asset Management LLC (Private Equity)
Profil
Dmitry Popov is the founder and managing partner of Maxwell Asset Management LLC, a private equity firm founded in 2008.
He is currently the Chief Executive Officer of MYR GmbH.
Aktive Positionen von Dmitry Popov
| Unternehmen | Position | Beginn |
|---|---|---|
Maxwell Asset Management LLC (Private Equity)
 Maxwell Asset Management LLC (Private Equity) Investment ManagersFinance Maxwell Asset Management LLC /Private Equity/ (Maxwell Asset Management) is the private equity and venture capital subsidiary of Maxwell Capital Group LLC. The firm was founded by Dmitry Popov in 2008. It is headquartered in Moscow, Russia with an additional office in Boston, USA. | Gründer | 01.01.2008 |
MYR GmbH
 MYR GmbH BiotechnologyHealth Technology MYR GmbH engages in operating an biotechnology company. It focuses on the development and commercialization of therapeutics for the treatment of chronic hepatitis B (HBV) and D (HDV) infections. The company was founded by Joern Moeller and Alexander Alexandrov in 2010 and is headquartered in Bad Homburg, Germany. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Maxwell Asset Management LLC (Private Equity)
Maxwell Asset Management LLC (Private Equity) Investment ManagersFinance Maxwell Asset Management LLC /Private Equity/ (Maxwell Asset Management) is the private equity and venture capital subsidiary of Maxwell Capital Group LLC. The firm was founded by Dmitry Popov in 2008. It is headquartered in Moscow, Russia with an additional office in Boston, USA. | Finance |
MYR GmbH
MYR GmbH BiotechnologyHealth Technology MYR GmbH engages in operating an biotechnology company. It focuses on the development and commercialization of therapeutics for the treatment of chronic hepatitis B (HBV) and D (HDV) infections. The company was founded by Joern Moeller and Alexander Alexandrov in 2010 and is headquartered in Bad Homburg, Germany. | Health Technology |
